Zobrazeno 1 - 10 of 130 pro vyhledávání: '"Abdalla DS"'
2
Akademický článek
Classification of individuals with dyslipidaemia controlled by statins according to plasma biomarkers of oxidative stress using cluster analysis.
Autor: Botelho PB, Fioratti CO, Abdalla DS, Bertolami MC, Castro IA
Publikováno v: British Journal of Nutrition; 2010 Jan 28, Vol. 103 Issue 2, p256-265, 10p
Zobrazit plný text záznamu
4
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
5
Akademický článek
Bioactivity of nitrolinoleate: effects on adhesion molecules and CD40-CD40L system.
Autor: Faine LA (AUTHOR), Cavalcanti DM (AUTHOR), Rudnicki M (AUTHOR), Ferderbar S (AUTHOR), Macedo SM (AUTHOR), Souza HP (AUTHOR), Farsky SH (AUTHOR), Boscá L (AUTHOR), Abdalla DS (AUTHOR)
Publikováno v: Journal of Nutritional Biochemistry. Feb2010, Vol. 21 Issue 2, p125-132. 8p.
Zobrazit plný text záznamu
6
Akademický článek
Increased levels of the soluble oncostatin M receptor (sOSMR) and glycoprotein 130 (sgp130) in systemic sclerosis patients and associations with clinical parameters.
Autor: de Almeida AR; Laboratório de Imunomodulação e Novas Abordagens Terapêuticas, Núcleo de Pesquisa em Inovação Terapêutica, Universidade Federal de Pernambuco, Recife, PE, Brazil., Dantas AT; Laboratório de Imunomodulação e Novas Abordagens Terapêuticas, Núcleo de Pesquisa em Inovação Terapêutica, Universidade Federal de Pernambuco, Recife, PE, Brazil; Serviço de Reumatologia, Hospital das Clínicas da Universidade Federal de Pernambuco, Recife, PE, Brazil., Pereira MC; Laboratório de Imunomodulação e Novas Abordagens Terapêuticas, Núcleo de Pesquisa em Inovação Terapêutica, Universidade Federal de Pernambuco, Recife, PE, Brazil., de Melo Rêgo MJB; Laboratório de Imunomodulação e Novas Abordagens Terapêuticas, Núcleo de Pesquisa em Inovação Terapêutica, Universidade Federal de Pernambuco, Recife, PE, Brazil., Guimarães Gonçalves RS; Laboratório de Imunomodulação e Novas Abordagens Terapêuticas, Núcleo de Pesquisa em Inovação Terapêutica, Universidade Federal de Pernambuco, Recife, PE, Brazil; Serviço de Reumatologia, Hospital das Clínicas da Universidade Federal de Pernambuco, Recife, PE, Brazil., Pitta IDR; Laboratório de Imunomodulação e Novas Abordagens Terapêuticas, Núcleo de Pesquisa em Inovação Terapêutica, Universidade Federal de Pernambuco, Recife, PE, Brazil., Branco Pinto Duarte AL; Laboratório de Imunomodulação e Novas Abordagens Terapêuticas, Núcleo de Pesquisa em Inovação Terapêutica, Universidade Federal de Pernambuco, Recife, PE, Brazil; Serviço de Reumatologia, Hospital das Clínicas da Universidade Federal de Pernambuco, Recife, PE, Brazil., Parra Abdalla DS; Departamento de Análises Clínicas e Toxicológicas, Faculdade de Ciências Farmacêuticas, Universidade de São Paulo, São Paulo, SP, Brazil., da Rocha Pitta MG; Laboratório de Imunomodulação e Novas Abordagens Terapêuticas, Núcleo de Pesquisa em Inovação Terapêutica, Universidade Federal de Pernambuco, Recife, PE, Brazil. Electronic address: maira.pitta@ufpe.br.
Publikováno v: Immunobiology [Immunobiology] 2020 May; Vol. 225 (3), pp. 151964. Date of Electronic Publication: 2020 May 22.
Zobrazit plný text záznamu
7
Akademický článek
A nanoformulation containing a scFv reactive to electronegative LDL inhibits atherosclerosis in LDL receptor knockout mice.
Autor: Cavalcante MF; Department of Clinical and Toxicological Analyses, Faculty of Pharmaceutical Sciences, University of Sao Paulo, Sao Paulo, SP, Brazil., Kazuma SM; Department of Clinical and Toxicological Analyses, Faculty of Pharmaceutical Sciences, University of Sao Paulo, Sao Paulo, SP, Brazil., Bender EA; Department of Organic Chemistry, Chemistry Institute, Federal University of Rio Grande do Sul, Porto Alegre, RS, Brazil., Adorne MD; Department of Organic Chemistry, Chemistry Institute, Federal University of Rio Grande do Sul, Porto Alegre, RS, Brazil., Ullian M; Department of Clinical and Toxicological Analyses, Faculty of Pharmaceutical Sciences, University of Sao Paulo, Sao Paulo, SP, Brazil., Veras MM; LIM5, Department of Pathology, Medicine School, University of Sao Paulo, Sao Paulo, SP, Brazil., Saldiva PH; LIM5, Department of Pathology, Medicine School, University of Sao Paulo, Sao Paulo, SP, Brazil., Maranhão AQ; Molecular Immunology Laboratory, Department of Cell Biology, University of Brasilia, Brasilia, Distrito Federal, Brazil., Guterres SS; Department of Production and Control of Medicines, Faculty of Pharmacy, Federal University of Rio Grande do Sul, Porto Alegre, RS, Brazil., Pohlmann AR; Department of Organic Chemistry, Chemistry Institute, Federal University of Rio Grande do Sul, Porto Alegre, RS, Brazil., Abdalla DS; Department of Clinical and Toxicological Analyses, Faculty of Pharmaceutical Sciences, University of Sao Paulo, Sao Paulo, SP, Brazil. Electronic address: dspabdalla@gmail.com.
Publikováno v: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V [Eur J Pharm Biopharm] 2016 Oct; Vol. 107, pp. 120-9. Date of Electronic Publication: 2016 Jul 01.
Zobrazit plný text záznamu
8
Akademický článek
Acute modification in plasma lipid levels in ultramarathon runners.
Autor: Emed LG; a School of Medicine , Pontifícia Universidade Católica do Paraná, PUC-PR , Curitiba , PR , Brazil.; b Hospital Cardiologico Costantini , Curitiba , PR , Brazil., Passaglia DG; a School of Medicine , Pontifícia Universidade Católica do Paraná, PUC-PR , Curitiba , PR , Brazil., Guerios ST; a School of Medicine , Pontifícia Universidade Católica do Paraná, PUC-PR , Curitiba , PR , Brazil., João PG; a School of Medicine , Pontifícia Universidade Católica do Paraná, PUC-PR , Curitiba , PR , Brazil., Moser AI; a School of Medicine , Pontifícia Universidade Católica do Paraná, PUC-PR , Curitiba , PR , Brazil., Abdalla DS; c Faculdade de Ciências Farmacêuticas , Universidade de São Paulo , São Paulo , Brazil., Guarita-Souza LC; a School of Medicine , Pontifícia Universidade Católica do Paraná, PUC-PR , Curitiba , PR , Brazil.; b Hospital Cardiologico Costantini , Curitiba , PR , Brazil., Mikilita ES; a School of Medicine , Pontifícia Universidade Católica do Paraná, PUC-PR , Curitiba , PR , Brazil., Baena CP; a School of Medicine , Pontifícia Universidade Católica do Paraná, PUC-PR , Curitiba , PR , Brazil., da Costa AB; a School of Medicine , Pontifícia Universidade Católica do Paraná, PUC-PR , Curitiba , PR , Brazil., Faria-Neto JR; a School of Medicine , Pontifícia Universidade Católica do Paraná, PUC-PR , Curitiba , PR , Brazil.
Publikováno v: Journal of sports sciences [J Sports Sci] 2016 Sep; Vol. 34 (17), pp. 1657-61. Date of Electronic Publication: 2015 Dec 29.
Zobrazit plný text záznamu
9
Akademický článek
CTHRSSVVC Peptide as a Possible Early Molecular Imaging Target for Atherosclerosis.
Autor: Silva RA; Laboratory of Immunology, Heart Institute (InCor), Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo 05403-000, Brazil. uitroseme@gmail.com., Giordano RJ; Chemistry Institute, Biochemistry Department, University of Sao Paulo, Sao Paulo 05508-000, Brazil. giordano@iq.usp.br., Gutierrez PS; Laboratory of Pathology, Heart Institute (InCor), Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo 05403-000, Brazil. paulo.gutierrez@incor.usp.br., Rocha VZ; Clinical Division, Heart Institute (InCor), Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo 05403-000, Brazil. vzrocha@hotmail.com., Rudnicki M; Department of Clinical and Toxicological Analyses, Faculty of Pharmaceutical Sciences University of São Paulo, São Paulo 05508-000, Brazil. martina.rudnicki@gmail.com., Kee P; Division of Cardiology, Department of Internal Medicine, The University of Texas Health Science Center at Houston, Houston, TX 77054, USA. patrick.kee@uth.tmc.edu., Abdalla DS; Department of Clinical and Toxicological Analyses, Faculty of Pharmaceutical Sciences University of São Paulo, São Paulo 05508-000, Brazil. dspabdalla@gmail.com., Puech-Leão P; Division of Vascular and Endovascular Surgery, University of São Paulo Medical School, São Paulo 05403-000, Brazil. pedro@puech.com.br., Caramelli B; Clinical Division, Heart Institute (InCor), Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo 05403-000, Brazil. bcaramel@usp.br., Arap W; University of New Mexico Comprehensive Cancer Center, Division of Hematology/Oncology and Division of Molecular Medicine, Department of Internal Medicine, University of New Mexico School of Medicine Albuquerque, NM 87131, USA. warap@salud.unm.edu., Pasqualini R; University of New Mexico Comprehensive Cancer Center, Division of Hematology/Oncology and Division of Molecular Medicine, Department of Internal Medicine, University of New Mexico School of Medicine Albuquerque, NM 87131, USA. rpasqual@salud.unm.edu., Meneghetti JC; Medicine Nuclear Service and Molecular Image, Heart Institute (InCor), Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo 05403-000, Brazil. meneghetti@incor.usp.br., Marques FL; Departamento de Radiologia e Oncologia, Faculdade de Medicina da Universidade de São Paulo (LIM43), São Paulo 05403-911, Brazil. fabio.marques@fm.usp.br., Khoobchandani M; Institute of Green Nanotechnology, Department of Radiology and Chemistry, University of Missouri, Columbia, MO 65211, USA. khoobchandanim@health.missouri.edu., Katti KV; Institute of Green Nanotechnology, Department of Radiology and Chemistry, University of Missouri, Columbia, MO 65211, USA. kattik@health.missouri.edu., Lugão AB; Nuclear and Energy Research Institute-IPEN/CNEN/São Paulo 05508-000, Brazil. ablugao@gmail.com., Kalil J; Laboratory of Immunology, Heart Institute (InCor), Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo 05403-000, Brazil. jkalil@usp.br.
Publikováno v: International journal of molecular sciences [Int J Mol Sci] 2016 Aug 24; Vol. 17 (9). Date of Electronic Publication: 2016 Aug 24.
Zobrazit plný text záznamu
10
Akademický článek
New thiazolidinediones affect endothelial cell activation and angiogenesis.
Autor: Rudnicki M; Department of Clinical and Toxicological Analyses, Faculty of Pharmaceutical Sciences, University of São Paulo, São Paulo, SP, Brazil., Tripodi GL; Department of Clinical and Toxicological Analyses, Faculty of Pharmaceutical Sciences, University of São Paulo, São Paulo, SP, Brazil., Ferrer R; Department of Clinical and Toxicological Analyses, Faculty of Pharmaceutical Sciences, University of São Paulo, São Paulo, SP, Brazil., Boscá L; Instituto de Investigaciones Biomédicas Alberto Sols (CSIC-UAM), Madrid, Spain., Pitta MG; Core of Therapeutic Innovation, Federal University of Pernambuco, Recife, PE, Brazil., Pitta IR; Core of Therapeutic Innovation, Federal University of Pernambuco, Recife, PE, Brazil., Abdalla DS; Department of Clinical and Toxicological Analyses, Faculty of Pharmaceutical Sciences, University of São Paulo, São Paulo, SP, Brazil. Electronic address: dspa@usp.br.
Publikováno v: European journal of pharmacology [Eur J Pharmacol] 2016 Jul 05; Vol. 782, pp. 98-106. Date of Electronic Publication: 2016 Apr 21.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje